ArticlePharmaceuticals (Basel, Switzerland)2026
Fluoroquinolone Exposure and Cancer Risk in Interstitial Lung Disease: A Propensity-Score-Matched Cohort Study Using Cox and Competing-Risk Models.
Yi-Fan Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.